Farmacología clásica (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Farmacología clásica" in Spanish language version.

refsWebsite

Global rank Spanish rank

11doi.org

2^nd place

9nih.gov

4^th place

1books.google.com

3^rd place

7^th place

1iaim.edu.in

low place

books.google.com

Pharmacology principles and practice. Amsterdam: Elsevier/Academic Press. 2009. p. 576. ISBN 0-12-369521-X.

doi.org

dx.doi.org

Takenaka T (September 2001). «Classical vs reverse pharmacology in drug discovery». BJU Int. 88 Suppl 2: 7-10; discussion 49-50. PMID 11589663. doi:10.1111/j.1464-410X.2001.00112.x.
Lazo JS (April 2008). «Rear-view mirrors and crystal balls: a brief reflection on drug discovery». Mol. Interv. 8 (2): 60-3. PMID 18403648. doi:10.1124/mi.8.2.1.
«Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets». Pharmacol. Ther. 107 (2): 212-21. August 2005. PMID 15925410. doi:10.1016/j.pharmthera.2005.03.002.
«Modern phenotypic drug discovery is a viable, neoclassic pharma strategy». J. Med. Chem. 55 (10): 4527-38. May 2012. PMID 22409666. doi:10.1021/jm201649s.
«How were new medicines discovered?». Nat Rev Drug Discov 10 (7): 507-19. July 2011. PMID 21701501. doi:10.1038/nrd3480.
Kotz J (April 2012). «Phenotypic screening, take two». Science-Business eXchange 5 (15). doi:10.1038/scibx.2012.380.
Patwardhan B; Vaidya ADB. Chorghade M; Joshi SP (2008). «Reverse Pharmacology and Systems Approaches for Drug Discovery and Development». Current Bioactive Compounds 4 (4): 201-212. doi:10.2174/157340708786847870.
Vaidya ADB (2006). «Reverse pharmacological correlates of ayurvedic drug actions». Indian Journal of Pharmacology 38 (5): 311. doi:10.4103/0253-7613.27697.
Pathak N (April 2011). «Reverse pharmacology of Ayurvedic drugs includes mechanisms of molecular actions». J Ayurveda Integr Med 2 (2): 49-50. PMC 3131769. PMID 21760686. doi:10.4103/0975-9476.82512.
Lele RD (October 2010). «Beyond reverse pharmacology: Mechanism-based screening of Ayurvedic drugs». J Ayurveda Integr Med 1 (4): 257-65. PMC 3117317. PMID 21731372. doi:10.4103/0975-9476.74435.
«A "reverse pharmacology" approach for developing an anti-malarial phytomedicine». Malar. J. 10 Suppl 1: S8. March 2011. PMC 3059466. PMID 21411019. doi:10.1186/1475-2875-10-S1-S8.

iaim.edu.in

Patwardhan B; Vaidya ADB. Chorghade M; Joshi SP (2008). «Reverse Pharmacology and Systems Approaches for Drug Discovery and Development». Current Bioactive Compounds 4 (4): 201-212. doi:10.2174/157340708786847870.

nih.gov

ncbi.nlm.nih.gov

Takenaka T (September 2001). «Classical vs reverse pharmacology in drug discovery». BJU Int. 88 Suppl 2: 7-10; discussion 49-50. PMID 11589663. doi:10.1111/j.1464-410X.2001.00112.x.
Lazo JS (April 2008). «Rear-view mirrors and crystal balls: a brief reflection on drug discovery». Mol. Interv. 8 (2): 60-3. PMID 18403648. doi:10.1124/mi.8.2.1.
«Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets». Pharmacol. Ther. 107 (2): 212-21. August 2005. PMID 15925410. doi:10.1016/j.pharmthera.2005.03.002.
«Modern phenotypic drug discovery is a viable, neoclassic pharma strategy». J. Med. Chem. 55 (10): 4527-38. May 2012. PMID 22409666. doi:10.1021/jm201649s.
«How were new medicines discovered?». Nat Rev Drug Discov 10 (7): 507-19. July 2011. PMID 21701501. doi:10.1038/nrd3480.
Pathak N (April 2011). «Reverse pharmacology of Ayurvedic drugs includes mechanisms of molecular actions». J Ayurveda Integr Med 2 (2): 49-50. PMC 3131769. PMID 21760686. doi:10.4103/0975-9476.82512.
Lele RD (October 2010). «Beyond reverse pharmacology: Mechanism-based screening of Ayurvedic drugs». J Ayurveda Integr Med 1 (4): 257-65. PMC 3117317. PMID 21731372. doi:10.4103/0975-9476.74435.
«A "reverse pharmacology" approach for developing an anti-malarial phytomedicine». Malar. J. 10 Suppl 1: S8. March 2011. PMC 3059466. PMID 21411019. doi:10.1186/1475-2875-10-S1-S8.
«Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches». Indian J. Exp. Biol. 48 (3): 220-7. 2010. PMID 21046974.